Scientists discover an essential mechanism for maintaining bone density

by Hospital Universitari de Bellvitge

The research group on Cell Signaling and Bone Biology at IDIBELL and the UB has revealed the importance of the function of NRF2, a protein that regulates the expression of some genes in response to ox...

Read more

Identification of genes that cause resistance to treatment of the pathogenic fungus Candida

by IRB Barcelona - Instituto de Investigación Biomédica

Drug-resistant fungal infections are a growing problem. The work has been published in the journal Current Biology

Read more

Development of a generic anti-inflammatory drug for dogs

by Fundació Bosch i Gimpera

The new drug incorporates the necessary pharmaceutical technology to allow the adjustment of the dosage according to the weight of the dog

Read more

Progress in the maturity of the start-ups: the clinical phases

by GENESIS Biomed

The start-ups Oxolife, Peptomyc and aptaTargets, with which GENESIS Biomed collaborates, are advancing in their maturity with the initiation and development of clinical phases and are approaching an e...

Read more

A new drug increases the life expectancy of patients with very aggressive intraocular cancer

by Hospital Universitari de Bellvitge

Like cutaneous melanomas, it is caused by the uncontrolled proliferation of melanocytes, the cells that colored the skin. But unlike these, uveal melanoma, which represents between 3 and 5% of melanom...

Read more

JACC: A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

​The safety, availability, and robust biological effect of metoprolol could together be enough to consider its use in young patients admitted to the ICU with severe COVID-19

Read more

Nature Metabolism. CNIO researchers discover that a drug already in use in humans corrects obesity in mice, with no side effects

by CNIO - Centro Nacional de Investigaciones Oncológicas

It has long been known that obesity is an inflammatory disease, i.e. a chronic defensive reaction of the body to stress caused by excess nutrients.

Read more

Schedule a meeting with us!

by Asphalion

Are you developing a drug and need help with regulatory affairs?

Read more

New drug confirmed as a potential therapeutic agent for a rare disease, Friedreich's Ataxia

by IRB Lleida. Institut de Recerca Biomèdica

A recent study has confirmed the benefits of the drug leriglitazone in treating Friedrich's Ataxia, a rare disease that affects 2-4 people in 100,000 and for which there is currently no effective cure...

Read more

Next Stop, the Clinic - Preparing your new Drug for Clinical Research with SciFindern and Formulus®

by CAS, a division of the American Chemical Society

Things are going well for your latest drug molecule - it seems efficacious, you have assessed potential toxicity, and even determined a safe starting dose, and now you are ready to move to the clinic...

Read more

Sant Pau participates in a phase 2 study that achieves positive results on a drug to combat the cognitive complications of Parkinson’s

by Hospital de la Santa Creu i Sant Pau

Dr. Kulisevsky, director of the Movement Disorders Unit of the Sant Pau Hospital Neurology Service and head of the Parkinson’s Disease and Movement Disorders Research Group at the Sant Pau Research ...

Read more

The drug SAR405, the best inhibitor of autophagy

by IRB Lleida. Institut de Recerca Biomèdica

UdL research questions use of 3-methyladenine in studies because of its toxicity

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream